Medicine and Dentistry
Ablation
13%
Adverse Outcome
13%
All Cause Mortality
27%
Apoplexy
26%
Atherosclerosis
11%
Atrial Fibrillation
82%
Brain Ischemia
13%
Brugada Syndrome
49%
Cardiac Dysrhythmia
16%
Cardiovascular Disease
36%
Cardiovascular System
37%
Cohort Analysis
38%
Comorbidity
11%
Congestive Heart Failure
62%
COVID-19
19%
Diabetes
14%
Diabetes Mellitus
35%
Dipeptidyl Peptidase-4 Inhibitor
17%
Diseases
23%
Ejection Fraction
12%
Electrocardiogram
27%
Faintness
17%
Glycon
13%
Hazard Ratio
28%
Heart Atrium Remodeling
12%
Heart Left Ventricle Ejection Fraction
16%
Heart Ventricle Arrhythmia
23%
Hemoglobin A1c
12%
Malignant Neoplasm
24%
Maturity Onset Diabetes of the Young
39%
Meta-Analysis
93%
Myocardial Infarction
12%
New-Onset Atrial Fibrillation
17%
Observational Study
17%
Odds Ratio
22%
P Wave
14%
Patient with Type 2 Diabetes
18%
Percutaneous Coronary Intervention
11%
Proportional Hazards Model
17%
Prospective Cohort Study
14%
Prostate Cancer
11%
Recurrent Disease
11%
Repolarization
20%
Risk Stratification
48%
Sodium Glucose Cotransporter 2 Inhibitor
20%
Sudden Cardiac Death
29%
Systematic Review
95%
T-Peak to T-End
13%
Ventricular Fibrillation
14%
Ventricular Tachycardia
18%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
10%
All Cause Mortality
47%
Androgen
11%
Antiarrhythmic Agent
10%
Arrhythmogenesis
16%
Atherosclerosis
14%
Atrial Fibrillation
100%
Biological Marker
13%
Brain Ischemia
11%
Brugada Syndrome
13%
Cardiovascular Disease
33%
Cardiovascular Mortality
9%
Cardiovascular Risk
12%
Cerebrovascular Accident
27%
Cohort Study
61%
Combination Therapy
10%
Comorbidity
12%
Congestive Heart Failure
70%
Coronavirinae
18%
Diabetes Mellitus
54%
Dipeptidyl Peptidase IV Inhibitor
19%
Disease
35%
Fibrosis
10%
Heart Arrhythmia
37%
Heart Atrium Remodeling
21%
Heart Failure with Preserved Ejection Fraction
10%
Heart Infarction
18%
Heart Ventricle Arrhythmia
28%
Heart Ventricle Remodeling
11%
Heart Ventricle Tachycardia
15%
Hemoglobin A1c
12%
Heptanol
12%
Immune Checkpoint Inhibitor
15%
Ion Channel
8%
Leporidae
14%
Long QT Syndrome
10%
Malignant Neoplasm
29%
Metformin
14%
Myocardial Disease
9%
Myocarditis
9%
New-Onset Atrial Fibrillation
15%
Non Insulin Dependent Diabetes Mellitus
35%
Observational Study
18%
Prospective Cohort Study
10%
Prostate Cancer
17%
Randomized Controlled Trial
28%
Recurrent Disease
15%
Sodium Glucose Cotransporter 2 Inhibitor
29%
Sudden Cardiac Death
27%
Warfarin
10%
Biochemistry, Genetics and Molecular Biology
Action Potential
12%
Action Potential Duration
6%
All Cause Mortality
29%
APD90
7%
Atrial Fibrillation
74%
Blood Pressure
6%
Blood Pressure Variability
9%
Body Mass
6%
Brugada Syndrome
35%
C-Reactive Protein
8%
Cardiac Dysrhythmia
24%
Cardiac Muscle Cell
9%
Cardiac Resynchronization Therapy
6%
Cardiovascular Mortality
10%
Cochrane Library
7%
Cohort Study
34%
Dispersion
6%
Effective Refractory Period
5%
Electrocardiogram
16%
Embase
5%
Endoplasmic Reticulum Stress
10%
HDL-Cholesterol
6%
Heart Ejection Fraction
10%
Heptanol
14%
Hypokalemia
6%
Immune Checkpoints
6%
Ion Channel
9%
Leporidae
7%
Long Non-Coding RNA
6%
Long QT Syndrome
7%
Medline
12%
Mendelian Randomization
5%
Mitochondrial Disorder
9%
N-Terminus
5%
Observational Study
12%
Oxidative Stress
15%
P Wave
8%
Prospective Cohort Study
9%
Randomized Controlled Trial
6%
Repolarization
19%
Signal Transduction
8%
Sodium Channel
6%
Sodium-Glucose Cotransporter 2 Inhibitors
5%
ST Elevation
5%
Sudden Cardiac Death
10%
Systolic Blood Pressure
6%
Triglyceride
5%
Ventricular Fibrillation
9%
Ventricular Tachycardia
16%
